garcinol has been researched along with incb-018424 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmar, S; Bajusz, D; Berger-Becvar, A; Cumaraswamy, AA; de Araujo, ED; Freund, P; Grebien, F; Gunning, PT; Heyes, EC; Keserű, GM; Kubicek, S; Lardeau, CH; Maurer, B; Moriggl, R; Orlova, A; Park, J; Ruge, F; Sadovnik, I; Tin, G; Valent, P; Wingelhofer, B | 1 |
1 other study(ies) available for garcinol and incb-018424
Article | Year |
---|---|
Pharmacologic inhibition of STAT5 in acute myeloid leukemia.
Topics: Animals; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Synergism; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Nitriles; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; STAT5 Transcription Factor; Terpenes | 2018 |